China Pharmaceuticals Effects 1 For 3 Reverse Share Split

Published: Sep 29, 2010

XI’AN, China--(BUSINESS WIRE)--China Pharmaceuticals, Inc. (OTCBB: CFMID) (“China Pharmaceuticals, Inc.” or the “Company”), one of China’s leading manufacturers and distributors of prescription and over-the-counter pharmaceuticals, today announced that it has effected a 1 for 3 reverse share split as of September 22, 2010.

Back to news